These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35058711)
1. High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma. Wei YG; Yang CK; Wei ZL; Liao XW; He YF; Zhou X; Huang HS; Lan CL; Han CY; Peng T Int J Gen Med; 2022; 15():609-621. PubMed ID: 35058711 [TBL] [Abstract][Full Text] [Related]
2. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model. Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737 [TBL] [Abstract][Full Text] [Related]
3. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma. Luo Y; Liu H; Fu H; Ding GS; Teng F Front Immunol; 2022; 13():974377. PubMed ID: 36458010 [TBL] [Abstract][Full Text] [Related]
4. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Li L; Wang X; Ding Y; Hui N; Su B; Yang M Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879 [TBL] [Abstract][Full Text] [Related]
5. Wei Y; Lan C; Wang X; Zhou X; Liao X; Huang H; Wei Z; Li T; Peng T; Zhu G Int J Gen Med; 2023; 16():4377-4392. PubMed ID: 37789880 [TBL] [Abstract][Full Text] [Related]
6. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma. Li D; Chen B; Zeng Y; Wang H Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635 [TBL] [Abstract][Full Text] [Related]
7. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
8. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis. Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma. Qin J; Sun W; Zhang H; Wu Z; Shen J; Wang W; Wei Y; Liu Y; Gao Y; Xu H Front Genet; 2022; 13():951077. PubMed ID: 36160006 [No Abstract] [Full Text] [Related]
10. FOXP3 and SQSTM1/P62 correlate with prognosis and immune infiltration in hepatocellular carcinoma. Liu S; Zhang H; Yan J; Zhu J; Bai Z; Li X Pathol Res Pract; 2023 Feb; 242():154292. PubMed ID: 36630868 [TBL] [Abstract][Full Text] [Related]
11. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
12. Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma. Fan Y; Hou J; Liu X; Han B; Meng Y; Liu B; Chen F; Shang Y; Cao P; Tan K Front Genet; 2021; 12():668516. PubMed ID: 34917120 [TBL] [Abstract][Full Text] [Related]
13. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity. Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839 [TBL] [Abstract][Full Text] [Related]
14. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G Front Genet; 2022; 13():959832. PubMed ID: 36299588 [No Abstract] [Full Text] [Related]
16. Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma. Zhang Y; Wang X; Wang H; Jiang Y; Xu Z; Luo L Front Oncol; 2022; 12():893107. PubMed ID: 35860579 [TBL] [Abstract][Full Text] [Related]
17. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. Zhang B; Tang B; Gao J; Li J; Kong L; Qin L J Transl Med; 2020 Sep; 18(1):342. PubMed ID: 32887635 [TBL] [Abstract][Full Text] [Related]
18. Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model. Cao H; Huang P; Qiu J; Gong X; Cao H Heliyon; 2024 Feb; 10(3):e24861. PubMed ID: 38317886 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma. Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W Front Immunol; 2022; 13():831101. PubMed ID: 35371079 [TBL] [Abstract][Full Text] [Related]
20. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]